For the first time since the COVID-19 pandemic upended global health systems, there’s a glimmer of hope in the fight against tuberculosis (TB). The World Health Organization (WHO) has reported a 2% drop in global TB rates in 2024, marking a significant turnaround after three consecutive years of increases fueled by pandemic-related disruptions to diagnosis and treatment. But here’s where it gets controversial: while this decline is a step in the right direction, it’s still not enough to meet the ambitious 2030 targets set by the WHO’s End TB Strategy.
Most indicators suggest the tide is turning—fewer cases, fewer deaths, and improved access to care. Yet, progress remains uneven, and funding cuts to international aid in low- and middle-income countries threaten to undo years of hard-won gains. WHO Director-General Tedros Adhanom Ghebreyesus warned, “We cannot afford to backslide now.”
Let’s break it down: In 2024, 1.23 million people died from TB, a 29% drop since 2015. While this is progress, it falls far short of the WHO’s goals—a 75% reduction by 2025 and a 90% reduction by 2030. And this is the part most people miss: even as global rates decline, certain regions, like Europe, are seeing alarming spikes, such as a 10% rise in child TB infections, as highlighted in a recent WHO call to action.
The End TB Strategy, adopted in 2014-2015, set clear milestones for 2020, 2025, 2030, and 2035, aiming to drastically cut TB incidence, deaths, and patient costs. But with funding gaps widening and health systems still recovering from the pandemic, achieving these goals feels increasingly like an uphill battle.
Here’s the controversial question: Are global health priorities misaligned, or is TB simply not getting the attention it deserves? With COVID-19 dominating headlines and resources, TB—a centuries-old disease—has often been overshadowed. Yet, it remains one of the top infectious killers worldwide.
What do you think? Is the world doing enough to end TB, or are we falling short? Share your thoughts in the comments—let’s spark a conversation that could shape the future of global health.
